Zacks Research Issues Positive Outlook for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHCFree Report) – Equities research analysts at Zacks Research boosted their Q3 2025 earnings per share (EPS) estimates for shares of Phibro Animal Health in a research report issued on Wednesday, March 12th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.50 for the quarter, up from their prior estimate of $0.48. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.51 EPS, Q2 2026 earnings at $0.56 EPS, Q3 2026 earnings at $0.50 EPS, Q4 2026 earnings at $0.60 EPS, FY2026 earnings at $1.96 EPS, Q2 2027 earnings at $0.56 EPS and FY2027 earnings at $2.21 EPS.

A number of other equities research analysts have also recently issued reports on PAHC. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Friday, March 7th. Finally, Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $21.00.

View Our Latest Stock Report on PAHC

Phibro Animal Health Trading Down 7.1 %

NASDAQ PAHC opened at $20.49 on Friday. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The stock has a 50 day moving average of $22.56 and a 200-day moving average of $22.56. Phibro Animal Health has a 12 month low of $11.98 and a 12 month high of $26.55. The company has a market cap of $829.91 million, a PE ratio of 42.69, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.34%. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Institutional Trading of Phibro Animal Health

Several large investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Phibro Animal Health during the 4th quarter worth approximately $29,000. Lazard Asset Management LLC increased its position in Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after purchasing an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in Phibro Animal Health in the 4th quarter worth about $69,000. Virtus Fund Advisers LLC bought a new position in Phibro Animal Health in the fourth quarter valued at about $69,000. Finally, Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health during the third quarter worth $70,000. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Read More

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.